Cargando…

A Contactless and Biocompatible Approach for 3D Active Microrobotic Targeted Drug Delivery

As robotic tools are becoming a fundamental part of present day surgical interventions, microrobotic surgery is steadily approaching clinically-relevant scenarios. In particular, minimally invasive microrobotic targeted drug deliveries are reaching the grasp of the current state-of-the-art technolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Ongaro, Federico, Niehoff, Dennis, Mohanty, Sumit, Misra, Sarthak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722705/
https://www.ncbi.nlm.nih.gov/pubmed/31370254
http://dx.doi.org/10.3390/mi10080504
_version_ 1783448600374673408
author Ongaro, Federico
Niehoff, Dennis
Mohanty, Sumit
Misra, Sarthak
author_facet Ongaro, Federico
Niehoff, Dennis
Mohanty, Sumit
Misra, Sarthak
author_sort Ongaro, Federico
collection PubMed
description As robotic tools are becoming a fundamental part of present day surgical interventions, microrobotic surgery is steadily approaching clinically-relevant scenarios. In particular, minimally invasive microrobotic targeted drug deliveries are reaching the grasp of the current state-of-the-art technology. However, clinically-relevant issues, such as lack of biocompatibility and dexterity, complicate the clinical application of the results obtained in controlled environments. Consequently, in this work we present a proof-of-concept fully contactless and biocompatible approach for active targeted delivery of a drug-model. In order to achieve full biocompatiblity and contacless actuation, magnetic fields are used for motion control, ultrasound is used for imaging, and induction heating is used for active drug-model release. The presented system is validated in a three-dimensional phantom of human vessels, performing ten trials that mimic targeted drug delivery using a drug-coated microrobot. The system is capable of closed-loop motion control with average velocity and positioning error of 0.3 mm/s and 0.4 mm, respectively. Overall, our findings suggest that the presented approach could augment the current capabilities of microrobotic tools, helping the development of clinically-relevant approaches for active in-vivo targeted drug delivery.
format Online
Article
Text
id pubmed-6722705
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67227052019-09-10 A Contactless and Biocompatible Approach for 3D Active Microrobotic Targeted Drug Delivery Ongaro, Federico Niehoff, Dennis Mohanty, Sumit Misra, Sarthak Micromachines (Basel) Article As robotic tools are becoming a fundamental part of present day surgical interventions, microrobotic surgery is steadily approaching clinically-relevant scenarios. In particular, minimally invasive microrobotic targeted drug deliveries are reaching the grasp of the current state-of-the-art technology. However, clinically-relevant issues, such as lack of biocompatibility and dexterity, complicate the clinical application of the results obtained in controlled environments. Consequently, in this work we present a proof-of-concept fully contactless and biocompatible approach for active targeted delivery of a drug-model. In order to achieve full biocompatiblity and contacless actuation, magnetic fields are used for motion control, ultrasound is used for imaging, and induction heating is used for active drug-model release. The presented system is validated in a three-dimensional phantom of human vessels, performing ten trials that mimic targeted drug delivery using a drug-coated microrobot. The system is capable of closed-loop motion control with average velocity and positioning error of 0.3 mm/s and 0.4 mm, respectively. Overall, our findings suggest that the presented approach could augment the current capabilities of microrobotic tools, helping the development of clinically-relevant approaches for active in-vivo targeted drug delivery. MDPI 2019-07-31 /pmc/articles/PMC6722705/ /pubmed/31370254 http://dx.doi.org/10.3390/mi10080504 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ongaro, Federico
Niehoff, Dennis
Mohanty, Sumit
Misra, Sarthak
A Contactless and Biocompatible Approach for 3D Active Microrobotic Targeted Drug Delivery
title A Contactless and Biocompatible Approach for 3D Active Microrobotic Targeted Drug Delivery
title_full A Contactless and Biocompatible Approach for 3D Active Microrobotic Targeted Drug Delivery
title_fullStr A Contactless and Biocompatible Approach for 3D Active Microrobotic Targeted Drug Delivery
title_full_unstemmed A Contactless and Biocompatible Approach for 3D Active Microrobotic Targeted Drug Delivery
title_short A Contactless and Biocompatible Approach for 3D Active Microrobotic Targeted Drug Delivery
title_sort contactless and biocompatible approach for 3d active microrobotic targeted drug delivery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722705/
https://www.ncbi.nlm.nih.gov/pubmed/31370254
http://dx.doi.org/10.3390/mi10080504
work_keys_str_mv AT ongarofederico acontactlessandbiocompatibleapproachfor3dactivemicrorobotictargeteddrugdelivery
AT niehoffdennis acontactlessandbiocompatibleapproachfor3dactivemicrorobotictargeteddrugdelivery
AT mohantysumit acontactlessandbiocompatibleapproachfor3dactivemicrorobotictargeteddrugdelivery
AT misrasarthak acontactlessandbiocompatibleapproachfor3dactivemicrorobotictargeteddrugdelivery
AT ongarofederico contactlessandbiocompatibleapproachfor3dactivemicrorobotictargeteddrugdelivery
AT niehoffdennis contactlessandbiocompatibleapproachfor3dactivemicrorobotictargeteddrugdelivery
AT mohantysumit contactlessandbiocompatibleapproachfor3dactivemicrorobotictargeteddrugdelivery
AT misrasarthak contactlessandbiocompatibleapproachfor3dactivemicrorobotictargeteddrugdelivery